(VIANEWS) – The NASDAQ ended the session with Pacific Biosciences of California rising 6.8% to $5.57 on Thursday, after two consecutive sessions in a row of losses. NASDAQ fell 0.26% to $11,388.50, following the last session’s downward trend on what was a somewhat negative trend exchanging session today.

Volume

Today’s last reported volume for Pacific Biosciences of California is 4841850, 22.9% below its average volume of 6280640.

Pacific Biosciences of California’s last close was $5.22, 85.64% below its 52-week high of $36.36.

Pacific Biosciences of California’s Sales

Pacific Biosciences of California’s sales growth is 33.8% for the present quarter and 48.3% for the next. The company’s growth estimates for the current quarter is a negative 178.4% and positive 40% for the next.

Pacific Biosciences of California’s Revenue

Year-on-year quarterly revenue growth grew by 32.7%, now sitting on 130.51M for the twelve trailing months.

Pacific Biosciences of California’s Stock Yearly Top and Bottom Value

Pacific Biosciences of California’s stock is valued at $5.57 at 19:29 EST, way below its 52-week high of $36.36 and way higher than its 52-week low of $4.51.

Pacific Biosciences of California’s Moving Average

Pacific Biosciences of California’s value is way below its 50-day moving average of $8.33 and way below its 200-day moving average of $18.79.

More news about Pacific Biosciences of California (PACB).

LEAVE A REPLY

Please enter your comment!
Please enter your name here